Vadim Alexandre discusses a big U.S. AI deal within biotech and suggests this is just the start

Episode 1537, Jul 14, 2023, 08:18 AM

Vadim Alexandre, Head of Healthcare at SP Angel discusses a big U.S. AI deal within biotech and suggests this is just the start. Companies mentioned:

e-Therapeutics #ETX

Audioboom uses Javascript

Please enable it in your browser's preferences.

You can visit our support center if you're having problems.

Sorry, your browser isn't supported by Audioboom.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

You can visit our support center if you're having problems.

Vadim Alexandre discusses a big U.S. AI deal within biotech and suggests this is just the start

Subscribe

Next

John Meyer on China's deflation plus Bushveld Minerals, Empire Metals & Strategic Minerals

Top episodes

Is a house price crash coming?

Alastair Smith of Avacta: Successful Completion of Fourth Dose Escalation in AVA6000 Study

Vox Markets Interview with Avacta CEO Alastair Smith

Related episodes

Vadim Alexandre: Delisting of UK Companies, going to the U.S. is a Trend and a Problem

Is it Time to Take Advantage of Negative Market Sentiment?

Ali Mortazavi of e-therapeutics: 2023 was a Year of Remarkable Progress

Sorry, your browser isn't supported by Audioboom.

Page load failed